Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05403450 |
|---|---|
| Brief Title: | A Study of Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL) |
| First Submitted : | May 23, 2022 |
| First Submitted that Met QC Criteria : | May 31, 2022 |
| First Posted : | June 3, 2022 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 6, 2024 |